Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

NCT00471549 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Statin (simvastatin)

Sponsor

University of Aarhus